Adam Maeder

Adam Maeder is a director and senior research analyst focused on the medical technology sector. Prior to joining Piper Sandler in 2019, Maeder worked in medical technology equity research at Wells Fargo Securities. Additionally, he worked at Westwicke Partners providing investor relations strategy and capital markets advisory to medical technology and diagnostics companies. Maeder began his career working on the equity capital markets desk at Piper Sandler. Maeder holds a BBA in finance from the University of Iowa.

Universe Coverage

Medical Technology and Devices
ABT	Abbott Laboratories
AXNX	Axonics, Inc.
EW	Edwards Lifesciences Corporation
NARI	Inari Medical, Inc.
INSP	Inspire Medical Systems, Inc.
NSPR	InspireMD, Inc.
ISRG	Intuitive Surgical, Inc.
LIVN	LivaNova
STIM	Neuronetics, Inc.
NVRO	Nevro Corp.
NYXH	Nyxoah SA
STXS	Stereotaxis, Inc.
TCMD	Tactile Systems Technology, Inc.
RBOT	Vicarious Surgical, Inc.